Skip to main content

Advertisement

SpringerLink
Log in

Technology and intensive management in youth with type 1 diabetes: State of the art

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Recent implementation of technologic advances in the management of pediatric type 1 diabetes creates an exciting time for the diabetes community. Safety and efficacy of new therapies are commonly demonstrated first in adult patients with pediatric studies following. This review covers recent advances in six main areas: blood glucose monitoring including continuous monitoring; point-of-care A1c testing; designer insulins; insulin delivery systems including insulin pumps; electronic communication; and telehealth.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Urbach SL, LaFranchi S, Lambert L, et al.: Predictors of glucose control in children and adolescents with type 1 diabetes mellitus. Pediatr Diabetes 2005, 6:69–74.

    Article  PubMed  Google Scholar 

  2. Haller MJ, Stalvey MS, Silverstein JH: Predictors of control of diabetes: monitoring may be the key. J Pediatr 2004, 144:660–661.

    Article  PubMed  Google Scholar 

  3. Bui H, Perlman K, Daneman D: Self-monitoring of blood glucose in children and teens with diabetes. Pediatr Diabetes 2005, 6:50–62.

    Article  PubMed  Google Scholar 

  4. Lucidarme N, Alberti C, Zaccaria I, et al.: Alternate-site testing is reliable in children and adolescents with type 1 diabetes, except at the forearm for hypoglycemia detection. Diabetes Care 2005, 28:710–711.

    Article  PubMed  Google Scholar 

  5. Garg S, Zisser H, Schwartz S, et al.: Improvement in glycemic excursions with a transcutaneous, real-time continuous glucose sensor: a randomized controlled trial. Diabetes Care 2006, 29:44–50.

    Article  PubMed  CAS  Google Scholar 

  6. Lagarde WH, Barrows FP, Davenport ML, et al.: Continuous subcutaneous glucose monitoring in children with type 1 diabetes mellitus: a single-blind, randomized, controlled trial. Pediatr Diabetes 2006, 7:159–164.

    Article  PubMed  Google Scholar 

  7. Yates K, Hasnat MA, Dear K, et al.: Continuous glucose monitoring-guided insulin adjustment in children and adolescents on near-physiological insulin regimens: a randomized controlled trial. Diabetes Care 2006, 29:1512–1517.

    Article  PubMed  CAS  Google Scholar 

  8. Clarke WL, Anderson S, Farhy L, et al.: Evaluating the clinical accuracy of two continuous glucose sensors using continuous glucose-error grid analysis. Diabetes Care 2005, 28:2412–2417.

    Article  PubMed  CAS  Google Scholar 

  9. Chase HP, Roberts MD, Wightman C, et al.: Use of the GlucoWatch biographer in children with type 1 diabetes. Pediatrics 2003, 111:790–794.

    Article  PubMed  Google Scholar 

  10. Chase HP, Beck R, Tamborlane W, et al.: A randomized multicenter trial comparing the GlucoWatch Biographer with standard glucose monitoring in children with type 1 diabetes. Diabetes Care 2005, 28:1101–1106.

    Article  PubMed  Google Scholar 

  11. The Diabetes Research in Children Network (DirecNet) Study Group: Psychological aspects of continuous glucose monitoring in pediatric type 1 diabetes. Pediatr Diabetes 2006, 7:32–38.

    Article  Google Scholar 

  12. Larsen ML, Horder M, Mogensen EF: Effect of long-term monitoring of glycosylated hemoglobin levels in insulin-dependent diabetes mellitus. N Engl J Med 1990, 323:1021–1025.

    Article  PubMed  CAS  Google Scholar 

  13. Tamborlane WV, Kollman C, Steffes MW, et al.: Comparison of fingerstick hemoglobin A1c levels assayed by DCA 2000 with the DCCT/EDIC central laboratory assay: results of a Diabetes Research in Children Network (DirecNet) Study. Pediatr Diabetes 2005, 6:13–16.

    Article  PubMed  Google Scholar 

  14. Kennedy L, Herman WH: Glycated hemoglobin assessment in clinical practice: comparison of the A1cNow point-of-care device with central laboratory testing (GOAL A1C Study). Diabetes Technol Ther 2005, 7:907–912.

    Article  PubMed  CAS  Google Scholar 

  15. Cagliero E, Levina EV, Nathan DM: Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diabetes Care 1999, 22:1785–1789.

    Article  PubMed  CAS  Google Scholar 

  16. Kennedy L, Herman WH, Strange P, et al.: Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial. Diabetes Care 2006, 29:1–8.

    Article  PubMed  CAS  Google Scholar 

  17. Hirsch IB: Insulin analogues. N Engl J Med 2005, 352:174–183.

    Article  PubMed  CAS  Google Scholar 

  18. Rave K, Klein O, Frick AD, et al.: Advantage of premeal-injected insulin glulisine compared with regular human insulin in subjects with type 1 diabetes. Diabetes Care 2006, 29:1812–1817.

    Article  PubMed  CAS  Google Scholar 

  19. Danne T, Becker RH, Heise T, et al.: Pharmacokinetics, prandial glucose control, and safety of insulin glulisine in children and adolescents with type 1 diabetes. Diabetes Care 2005, 28:2100–2105.

    Article  PubMed  CAS  Google Scholar 

  20. Kaplan W, Rodriguez LM, Smith OE, et al.: Effects of mixing glargine and short-acting insulin analogs on glucose control. Diabetes Care 2004, 27:2739–2740.

    Article  PubMed  Google Scholar 

  21. Fiallo-Scharer R, Horner B, McFann K, et al.: Mixing rapid-acting insulin analogues with insulin glargine in children with type 1 diabetes mellitus. J Pediatr 2006, 148:481–484.

    Article  PubMed  CAS  Google Scholar 

  22. Ratner RE, Hirsch IB, Neifing JL, et al.: Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes. Diabetes Care 2000, 23:639–643.

    Article  PubMed  CAS  Google Scholar 

  23. Schober E, Schoenle E, Van Dyk J, et al.: Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15:369–376.

    PubMed  CAS  Google Scholar 

  24. Hathout EH, Fujishige L, Geach J, et al.: Effect of therapy with insulin glargine (Lantus) on glycemic control in toddlers, children, and adolescents with diabetes. Diabetes Technol Ther 2003, 5:801–806.

    Article  PubMed  CAS  Google Scholar 

  25. Doyle EA, Weinzimer SA, Steffen AT, et al.: A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabetes Care 2004, 27:1554–1558.

    Article  PubMed  CAS  Google Scholar 

  26. Dixon B, Peter CH, Burdick J, et al.: Use of insulin glargine in children under age 6 with type 1 diabetes. Pediatr Diabetes 2005, 6:150–154.

    Article  PubMed  Google Scholar 

  27. Alemzadeh R, Berhe T, Wyatt DT: Flexible insulin therapy with glargine insulin improved glycemic control and reduced severe hypoglycemia among preschool-aged children with type 1 diabetes mellitus. Pediatrics 2005, 115:1320–1324.

    Article  PubMed  Google Scholar 

  28. Vague P, Selam JL, Skeie S, et al.: Insulin detemir is associated with more predictable glycemic control and reduced risk of hypoglycemia than NPH insulin in patients with type 1 diabetes on a basal-bolus regimen with premeal insulin aspart. Diabetes Care 2003, 26:590–596.

    Article  PubMed  CAS  Google Scholar 

  29. Kolendorf K, Ross GP, Pavlic-Renar I, et al.: Insulin detemir lowers the risk of hypoglycaemia and provides more consistent plasma glucose levels compared with NPH insulin in Type 1 diabetes. Diabet Med 2006, 23:729–735.

    Article  PubMed  CAS  Google Scholar 

  30. Danne T, Lupke K, Walte K, et al.: Insulin detemir is characterized by a consistent pharmacokinetic profile across age-groups in children, adolescents, and adults with type 1 diabetes. Diabetes Care 2003, 26:3087–3092.

    Article  PubMed  CAS  Google Scholar 

  31. Hanas R, Adolfsson P, Elfvin-Akesson K, et al.: Indwelling catheters used from the onset of diabetes decrease injection pain and pre-injection anxiety. J Pediatr 2002, 140:315–320.

    Article  PubMed  Google Scholar 

  32. American Diabetes Association: Insulin administration. Diabetes Care 2004, 27(suppl 1):S106–S109.

    Google Scholar 

  33. Weissberg-Benchell J, Antisdel-Lomaglio J, Seshadri R: Insulin pump therapy: a meta-analysis. Diabetes Care 2003, 26:1079–1087.

    Article  PubMed  Google Scholar 

  34. McMahon SK, Airey FL, Marangou DA, et al.: Insulin pump therapy in children and adolescents: improvements in key parameters of diabetes management including quality of life. Diabet Med 2005, 22:92–96.

    Article  PubMed  CAS  Google Scholar 

  35. Plotnick LP, Clark LM, Brancati FL, et al.: Safety and effectiveness of insulin pump therapy in children and adolescents with type 1 diabetes. Diabetes Care 2003, 26:1142–1146.

    Article  PubMed  Google Scholar 

  36. Willi SM, Planton J, Egede L, et al.: Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes. J Pediatr 2003, 143:796–801.

    Article  PubMed  CAS  Google Scholar 

  37. Weinzimer SA, Ahern JH, Doyle EA, et al.: Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report. Pediatrics 2004, 114:1601–1605.

    Article  PubMed  Google Scholar 

  38. Weintrob N, Benzaquen H, Galatzer A, et al.: Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 2003, 112:559–564.

    Article  PubMed  Google Scholar 

  39. Wilson DM, Buckingham BA, Kunselman EL, et al.: A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabetes Care 2005, 28:15–19.

    Article  PubMed  Google Scholar 

  40. Valenzuela JM, Patino AM, McCullough J, et al.: Insulin pump therapy and health-related quality of life in children and adolescents with type 1 diabetes. J Pediatr Psychol 2006, 31:650–660.

    Article  PubMed  Google Scholar 

  41. Eugster EA, Francis G: Position statement: Continuous subcutaneous insulin infusion in very young children with type 1 diabetes. Pediatrics 2006, 118:e1244–e1249.

    Article  PubMed  Google Scholar 

  42. Fox LA, Buckloh LM, Smith SD, et al.: A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabetes Care 2005, 28:1277–1281.

    Article  PubMed  CAS  Google Scholar 

  43. DiMeglio LA, Pottorff TM, Boyd SR, et al.: A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 2004, 145:380–384.

    Article  PubMed  CAS  Google Scholar 

  44. Wood JR, Moreland EC, Volkening LK, et al.: Durability of insulin pump use in pediatric patients with type 1 diabetes. Diabetes Care 2006, 29:2355–2360.

    Article  PubMed  Google Scholar 

  45. Strowig SM, Raskin P: Improved glycemic control in intensively treated type 1 diabetic patients using blood glucose meters with storage capability and computer-assisted analyses. Diabetes Care 1998, 21:1694–1698.

    Article  PubMed  CAS  Google Scholar 

  46. Laffel L, Hsu W, McGill J, et al.: Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial. Diabetes Technol Ther 2007, in press.

  47. Hirsch IB: Blood glucose monitoring technology: translating data into practice. Endocr Pract 2004, 10:67–76.

    PubMed  Google Scholar 

  48. Hanauer D, Laffel N, Wentzell K, et al.: Computerized Automated Reminder Diabetes System (CARDS): increasing adherence to diabetes management tasks via the Web and SMS text messaging [abstract]. Diabetes 2005, 54:A100.

    Article  Google Scholar 

  49. Kumar VS, Wentzell KJ, Mikkelsen T, et al.: The DAILY (Daily Automated Intensive Log for Youth) trial: a wireless, portable system to improve adherence and glycemic control in youth with diabetes. Diabetes Technol Ther 2004, 6:445–453.

    Article  PubMed  Google Scholar 

  50. Heidgerken AD, Adkins J, Storch EA, et al.: Telehealth intervention for adolescents with type 1 diabetes. J Pediatr 2006, 148:707–708.

    Article  PubMed  Google Scholar 

  51. Deiss D, Bolinder J, Riveline J, et al.: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006, 29:2730–2732.

    Article  PubMed  Google Scholar 

  52. Halvorson M, Carpenter S, Kaiserman K, Kaufman F: A pilot trial in pediatrics with the sensor-augmented pump: combining real-time continuous glucose monitoring with the insulin pump. J Pediatr 2007, 150:103–105.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Pediatric, Adolescent, and Young Adult Section, Joslin Diabetes Center, One Joslin Place, Boston, MA, 02215, USA

    Lori M. B. Laffel MD, MPH

Authors
  1. Jamie R. Wood MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lori M. B. Laffel MD, MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lori M. B. Laffel MD, MPH.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wood, J.R., Laffel, L.M.B. Technology and intensive management in youth with type 1 diabetes: State of the art. Curr Diab Rep 7, 104–113 (2007). https://doi.org/10.1007/s11892-007-0019-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-007-0019-1

Keywords

Search

Navigation